HD-OPM Archive
Topics › How to read research

Number needed to treat explained: short prevention trials understate long-term benefit

Louis Nervegna · Oct 12, 2025 · ♥ 14 reactions · 8 comments · original Facebook post
How to read researchStatinsHeart attack, stroke & procedures
AI summary & key facts

Louis explains NNT (1 divided by absolute risk reduction) and why it looks poor in short prevention trials, where heart attack risk is only 2-3% over a few years. He argues that diet, exercise and statins taken for decades could cut lifetime risk from about 20% to 10%, an NNT of about 10, and that NNTs from short trials shouldn't mislead.

en.wikipedia.orgNumber needed to treat - Wikipediaen.wikipedia.org

The number needed to treat (NNT) is an epidemiological measure used in communicating the effectiveness of a health-care intervention, typically a treatment with medication. But it applies to diet and exercise as well.

The NNT is the average number of patients who need to be treated in order to prevent one additional bad outcome.

Mathematically, NNT is the inverse of the absolute risk reduction (ARR). As a formula, NNT = 1/ARR. For example, if an intervention lowers absolute risk by 1%, then NNT = 1/0.01 = 100. You would have to treat 100 people in order to prevent one bad outcome.

In preventative cardiology, the statistic NNT is typically quoted for prevention trials running only a few years. The absolute risk of having a heart attack in just a few years in these trials is often only around 2-3%. So the NNT for any intervention in these trials is going to be high.

In other words, you are going to have to treat a lot of people in order to see complete prevention of one heart attack. For example, the absolute risk of having a heart attack might only drop from 3% to 2% as a result of the intervention in one of these prevention trials. This is an ARR of only 1%. So you would have to treat 100 people to fully prevent one heart attack in this short timeframe. NNT = 1 / 0.01 = 100

This is true for prevention trials testing any intervention, e.g. diet, exercise, statins, etc. That’s why most people in cardiology don’t care about NNT in prevention trials lasting only a few years.

To actually prevent a lot of heart attacks completely with diet, exercise, statins, etc. people have to do it long term. Doing it for a few years will only lower absolute risk from, say, 2-3% down to 1-2%. That’s a big deal for the 2-3 people who actually have a heart attack in that short timeframe, but not for the other 97-98 people who don’t.

Doing it for decades, on the other hand, can lower absolute risk a lot. For example, from 20% down to 10%. That’s when you really see a big effect:

↪ Statin absolute risk reduction is cumulative: 1-2% in trials, far more over a lifetime

In this longer term example, you would only need to treat 10 people in order to completely prevent one heart attack. ARR = 10%, NTT = 1 / 0.1 = 10.

That’s pretty darn good, given that 2 out of 10 people in the USA will have a heart attack in their lifetime. If you treat all 10, then you can completely prevent 1 of those 2 heart attacks. Al by just taking 30 seconds to swallow a tiny pill each day. Now the NNT looks very impressive.

This is all true for diet and exercise as well. It is true for the vast majority of interventions in cardiology prevention trials. The truth is that the absolute risk reductions from diet and exercise are in the ballpark of statins and other drugs in prevention trials lasting only a few years— and therefore so are the NNT’s. That’s why you must stick with diet/exercise long term in order to gain a major benefit, just like with statins and other medications. You’re going to get much less benefit in the short run. That’s just how the math works, as explained. It’s also why you get the most benefit by combining diet and exercise with medications.

It’s important to understand the basic math on all of this, so you are not mislead when people quote NNT’s from cardiology prevention trials.

——————————————————————-

I used Gemini AI to fact check my statement above for accuracy. The response is listed below:

(I recommend everyone does this.)

The premise that the Number Needed to Treat (NNT) in short-term prevention trials can be misleading is widely accepted among medical professionals, especially cardiologists. Critics point out that the NNT calculated from trials lasting only a few years does not capture the cumulative, long-term benefit of interventions like diet, exercise, and statins.

The core argument

The user's argument is well-grounded in the principles of evidence-based medicine and risk statistics.

Valid criticisms of NNT in preventative medicine

Beyond the duration of the trial, medical literature has identified other significant limitations with using NNT in preventative medicine:

NNT is not a fixed number; it is highly dependent on the baseline risk of the population being studied. A trial of statins in a high-risk population (e.g. secondary prevention) will yield a much lower NNT than a trial in a low-risk population (primary prevention), even if the proportional benefit is the same.

The bottom line

While NNT is a helpful tool for understanding treatment effects on an individual level, it is not without flaws, especially in the context of long-term primary prevention. The user correctly identifies that the short duration of many prevention trials, combined with the inherently low baseline risk of the study population, can produce misleadingly high NNTs. Clinicians recognize that the real value of interventions like diet, exercise, and statins is realized over decades, where the cumulative risk reduction becomes much more significant.

#nntHD #absoluteriskHD #dietHD #exerciseHD #statinsHD

← newer: Prolonged very low carb diets can suppress thyroid hormones older: A rule for deciding: don't bet your life on anything not pro →